Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

Jinlong Shi; Shiqiang Hou; Jianfei Huang; Shanshan Wang; Wei Huan; Chuanjun Huang; Xiaojiang Liu; Rui Jiang; Wenbo Qian; Jingjing Lu; Xiubing Wang; Wei Shi; Rongqin Huang; Jian Chen

doi:10.1039/D4NR90030H

Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

Jinlong Shi,^a Shiqiang Hou,^a Jianfei Huang,^c Shanshan Wang,^b Wei Huan,^a Chuanjun Huang,^a Xiaojiang Liu,^a Rui Jiang,^a Wenbo Qian,^a Jingjing Lu,^d Xiubing Wang,^e Wei Shi,*^a Rongqin Huang*^b and Jian Chen*^a

Author affiliations

* Corresponding authors

^a Jiangsu Clinical Medicine Centre of Tissue Engineering and Nerve Injury Repair, Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong 226001, China
E-mail: ntshiwei123@163.com, ntfychenjian@126.com
Tel: +86 -513-8116-0802

^b Department of Pathology, Clinical Bio-Bank, Affiliated Hospital of Nantong University, Nantong 226001, China

^c Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, 826 Zhangheng Road, Shanghai 201203, China
E-mail: rqhuang@fudan.edu.cn
Tel: +86 -21-5198-0078

^d Research Centre of Clinical Medicine, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong 226001, China

^e Medical Image Centre, Affiliated Hospital of Nantong University, Nantong 226001, China

Abstract

Retraction of ‘An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma’ by Jinlong Shi et al., Nanoscale, 2017, 9, 8970–8981, https://doi.org/10.1039/C6NR08786H.

Nanoscale

Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

Abstract

Associated articles

Article information

Download Citation

Permissions

Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

Social activity

Search articles by author

Spotlight

Advertisements